Found: 32
Select item for more details and to access through your institution.
EV20/NMS-P945, a Novel Thienoindole Based Antibody-Drug Conjugate Targeting HER-3 for Solid Tumors.
- Published in:
- Pharmaceutics, 2021, v. 13, n. 4, p. 483, doi. 10.3390/pharmaceutics13040483
- By:
- Publication type:
- Article
Engineered Human Nanoferritin Bearing the Drug Genz-644282 for Cancer Therapy.
- Published in:
- Pharmaceutics, 2020, v. 12, n. 10, p. 992, doi. 10.3390/pharmaceutics12100992
- By:
- Publication type:
- Article
HER3 targeting with an antibody‐drug conjugate bypasses resistance to anti‐HER2 therapies.
- Published in:
- EMBO Molecular Medicine, 2020, v. 12, n. 5, p. 1, doi. 10.15252/emmm.201911498
- By:
- Publication type:
- Article
High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01851-8
- By:
- Publication type:
- Article
Functional and prognostic significance of the genomic amplification of frizzled 6 ( FZD6) in breast cancer.
- Published in:
- Journal of Pathology, 2017, v. 241, n. 3, p. 350, doi. 10.1002/path.4841
- By:
- Publication type:
- Article
Antibody-Drug Conjugates: The New Frontier of Chemotherapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5510, doi. 10.3390/ijms21155510
- By:
- Publication type:
- Article
Therapeutic Efficacy of the Novel Stimuli-Sensitive Nano-Ferritins Containing Doxorubicin in a Head and Neck Cancer Model.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1555, doi. 10.3390/ijms18071555
- By:
- Publication type:
- Article
Concerted BAG3 and SIRPα blockade impairs pancreatic tumor growth.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-00817-9
- By:
- Publication type:
- Article
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1308-7
- By:
- Publication type:
- Article
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancer.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1191-2
- By:
- Publication type:
- Article
Cost-sensitive rainfall thresholds for shallow landslides.
- Published in:
- Landslides, 2021, v. 18, n. 9, p. 2979, doi. 10.1007/s10346-021-01707-4
- By:
- Publication type:
- Article
HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01692-8
- By:
- Publication type:
- Article
A Phosphoinositide 3-Kinase/Phospholipase Cgamma1 Pathway Regulates Fibroblast Growth Factor-Induced Capillary Tube Formation.
- Published in:
- PLoS ONE, 2009, v. 4, n. 12, p. 1, doi. 10.1371/journal.pone.0008285
- By:
- Publication type:
- Article
Loss of RALT/MIG-6 expression in ERBB2-amplified breast carcinomas enhances ErbB-2 oncogenic potency and favors resistance to Herceptin.
- Published in:
- Oncogene, 2005, v. 24, n. 28, p. 4540, doi. 10.1038/sj.onc.1208658
- By:
- Publication type:
- Article
Feedback inhibition by RALT controls signal output by the ErbB network.
- Published in:
- Oncogene, 2003, v. 22, n. 27, p. 4221, doi. 10.1038/sj.onc.1206516
- By:
- Publication type:
- Article
Expression of RALT, a feedback inhibitor of ErbB receptors, is subjected to an integrated transcriptional and post-translational control.
- Published in:
- Oncogene, 2002, v. 21, n. 42, p. 6530, doi. 10.1038/sj.onc.1205823
- By:
- Publication type:
- Article
Therapeutic Potential of Antibody-Drug Conjugate-Based Therapy in Head and Neck Cancer: A Systematic Review.
- Published in:
- Cancers, 2021, v. 13, n. 13, p. 3126, doi. 10.3390/cancers13133126
- By:
- Publication type:
- Article
Dual PDK1/Aurora Kinase A Inhibitors Reduce Pancreatic Cancer Cell Proliferation and Colony Formation.
- Published in:
- Cancers, 2019, v. 11, n. 11, p. 1695, doi. 10.3390/cancers11111695
- By:
- Publication type:
- Article
The mitotic checkpoint kinase BUB1 is a direct and actionable target of MYB in adenoid cystic carcinoma.
- Published in:
- FEBS Letters, 2024, v. 598, n. 2, p. 252, doi. 10.1002/1873-3468.14786
- By:
- Publication type:
- Article
Extracellular LGALS3BP: a potential disease marker and actionable target for antibody–drug conjugate therapy in glioblastoma.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 8, p. 1460, doi. 10.1002/1878-0261.13453
- By:
- Publication type:
- Article
Development of an anti‐BAG3 humanized antibody for treatment of pancreatic cancer.
- Published in:
- Molecular Oncology, 2019, v. 13, n. 6, p. 1388, doi. 10.1002/1878-0261.12492
- By:
- Publication type:
- Article
Accounting for the effect of forest and fragmentation in probabilistic rockfall hazard.
- Published in:
- Natural Hazards & Earth System Sciences, 2023, v. 23, n. 6, p. 2349, doi. 10.5194/nhess-23-2349-2023
- By:
- Publication type:
- Article
miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction.
- Published in:
- FASEB Journal, 2019, v. 33, n. 6, p. 6933, doi. 10.1096/fj.201802547R
- By:
- Publication type:
- Article
BAG3 induces fibroblasts to release key cytokines involved in pancreatic cell migration.
- Published in:
- Journal of Cellular Biochemistry, 2022, v. 123, n. 1, p. 65, doi. 10.1002/jcb.30172
- By:
- Publication type:
- Article
Cover Image, Volume 123, Number 1, January 2022.
- Published in:
- Journal of Cellular Biochemistry, 2022, v. 123, n. 1, p. i, doi. 10.1002/jcb.30223
- By:
- Publication type:
- Article
Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target.
- Published in:
- 2021
- By:
- Publication type:
- journal article
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
LGALS3BP is a potential target of antibody‐drug conjugates in oral squamous cell carcinoma.
- Published in:
- Oral Diseases, 2024, v. 30, n. 4, p. 2039, doi. 10.1111/odi.14719
- By:
- Publication type:
- Article
Breast cancer in the era of integrating "Omics" approaches.
- Published in:
- Oncogenesis, 2022, v. 11, n. 1, p. 1, doi. 10.1038/s41389-022-00393-8
- By:
- Publication type:
- Article
USP19 modulates cancer cell migration and invasion and acts as a novel prognostic marker in patients with early breast cancer.
- Published in:
- Oncogenesis, 2021, v. 10, n. 3, p. 1, doi. 10.1038/s41389-021-00318-x
- By:
- Publication type:
- Article
Repurposing a psychoactive drug for children with cancer: p27Kip1-dependent inhibition of metastatic neuroblastomas by Prozac.
- Published in:
- Oncogenesis, 2020, v. 9, n. 1, p. 1, doi. 10.1038/s41389-019-0186-3
- By:
- Publication type:
- Article
EV20-sss-vc/MMAF, an HER-3 targeting antibody-drug conjugate displays antitumor activity in liver cancer.
- Published in:
- Oncology Reports, 2021, v. 45, n. 2, p. 776
- By:
- Publication type:
- Article